Psyence Biomedical Ltd. (NASDAQ:PBM) shares rose 4.4% in premarket trading Monday after the company announced it will acquire equity securities in Psyence Labs Ltd. through a share-for-share exchange.

The decision represents one of the highest awards given to engineers. She joins a group of 130 engineers from the United States and 28 international members for the 2026 class.

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies ...

Two high school students from central Iowa will travel to Washington, D.C., with state senators, as part of the U.S. Senate ...

This week, Mad in America examines three articles around peer support in mental healthcare settings, including the creation ...

The University of Akron's BETA Lab received a grant from the American Heart Association to help develop new, less invasive heart valve implants.

Student design teams BlueHealer, Ilytra Medical, and UrInControl have been selected to participate in VentureWell’s E-Team ...

House Bill 7148, signed into law on Feb. 3, offers temporary reassurance to biomedical researchers by preserving pandemic-era health care flexibilities.

With a foundation in biomedical discovery, you’ll be prepared to explore, innovate, and improve lives. UB’s Biomedical Sciences program builds a strong foundation in biomedicine by linking discovery ...

Chronic subdural hematomas account for over 90,000 hospitalizations annually and are projected to become the most common neurosurgical condition by 2030. Current interventions-including surgery and ...